EXHIBIT 99.2

VIA SEDAR

June 5, 2023

Alberta Securities Commission

Autorité des marchés financiers (Québec)

British Columbia Securities Commission

Manitoba Securities Commission

New Brunswick Securities Commission

Service Newfoundland and Labrador

Nova Scotia Securities Commission

Ontario Securities Commission

Prince Edward Island Securities Office

Saskatchewan Financial Services Commission

Re: Report of Voting Results pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations(« NI 51-102 »)

Following the Annual Meeting of Shareholders of Liminal BioSciences Inc. (the “Company”) held virtually on June 5, 2023 (the “Meeting”), and in accordance with section 11.3 of NI 51-102, continuous disclosure obligations, we hereby advise you of the matters voted upon at the Meeting and the voting results, the whole as detailed in the Management Information Circular of the Company dated April 14, 2023 (the “Circular”). According to the scrutineers’ report, the shareholders present at the meeting, in person or by proxy, represented 2,235,519 common Shares, or 72.02% of the 3,104,222 common shares outstanding on April 26, 2023, the record date for the Meeting.

Election of Directors of the Company

The six (6) nominees set forth in the Circular were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected or appointed.

Name of Nominee	For		Withheld / Abstain
	Votes	%	Votes	%
Alek Krstajic	2,027,866	98.76	25,427	1.24
Simon Best	2,021,889	98.47	31,405	1.53
Gary Bridger	2,028,017	98.77	25,277	1.23
Neil A. Klompas	2,028,133	98.77	25,160	1.23
Eugene Siklos	2,027,982	98.77	25,311	1.23
Timothy Steven Wach	2,025,888	98.67	27,406	1.33

www.liminalbiosciences.com info@liminalbiosciences.com +1.450.781.0115 Liminal BioSciences inc. 440 Boul. Armand-Frappier, Suite 300 Laval, Québec, H7V4B4, Canada

Appointment of Auditors

PricewaterhouseCoopers LLP were appointed as auditors of the Company to hold office until the next annual meeting of shareholders, and the board of directors was authorized to fix the auditors’ remuneration.

For		Withheld / Abstain
Votes	%	Votes	%
2,211,279	98.95	23,570	1.05

Liminal BioSciences Inc.

(s) Marie Iskra

Marie Iskra

General Counsel

www.liminalbiosciences.com info@liminalbiosciences.com +1.450.781.0115 Liminal BioSciences inc. 440 Boul. Armand-Frappier, Suite 300 Laval, Québec, H7V4B4, Canada